Align Technology, Inc. (ALGN)
The Company designs, manufactures and markets the Invisalign system, a proprietary method for treating malocclusion, or the misalignment of teeth.
Recs
Very bad entry point, possibly can't be fixed. Looking for a position to get out. current -113 points. Returns towards S/P repeatedly in swings of 30% and more. Target uhm -75points?
notes are for my own use.
Recs
ALGN has a too high valuation compared to its sales potential.
Recs
dental products
Recs
New 52 week low. Double down on losing position. Alternative to metal and wire dental braces.
Recs
The stock is trading near its lowest prices ever, and this is one that's certain to rebound once the market improves. Could it go down further? Sure, but when consumers start spending money again, parents will spare no expense on their kids' health care, cosmetics included - and this will send the stock price back up.
The only two aspects of this stock that I'm not crazy about are it's Earnings Per Share (.34), and it's beta being a bit high. Otherwise, all their other stats seem very healthy. I especially like the fact that they're beefing up their spending on sales and marketing - a very smart move during a down economy that'll help position them for major gains during an economic turnaround.
Also, they've got a patented monopoly on their product. A few former employees of Align Technology tried to form their own company using what equated to the same product (the "Invisible Braces") at a cheaper cost to the consumer. Align Technologies sued them & won, and the spinoff company eventually dissolved. With that kind of power & control over their product, I'm optimistic that the Earnings Per Share will eventually improve.
Recs
Invisalign system stinks
Recs
Worst of breed in the industry. Bad technicals. Too much debt. difficult to compete in such a saturated industry filled with stronger players with better management, products, and cash on hand.
Recs
Great product just needs to gain some steam. I have personally used Invisalign and it is outstanding compared to braces. Unless someone fixes our teeth genetically before birth, then there will always be a need for their product
Recs
Had been hit with warranted negatvie news but as it so often happens the street threw out the baby with the bathwater. It is a good product and is not bound by a bull or Bear market but by Vanity; Parents and children alike.
It has a devoted following of its product, myself included.
The street will redicover it and it will be moving UP.
Recs
There is no reason for this to be going up. First of all it is an elective procedure that is only FDA approved for people over 18, adults, not your typical population for braces, so insurace don't cover it at all. It is more expensive than traditional braces. It takes longer than traditional braces to correct problems. The users must wear these plastic mouthpieces all day every day unless you are eating (this limits treatment success because it is hard for anyone to wear these 24/7, no mater what the company tells you. Lastly, it is usually required to shave in-between teeth to achieve the desired result.
Now the Fundies: The company trades at an astounding P/E ratio. It has warned about future earnings. The CFO resigned. Cramer gave it a big "thumbs up."
This pig is being bought by the poor sappy dentists who pay a few grand for ALGN's course and think that they will be able to talk their patients into doing the treatment. Once they see that the treatment is not as successful as the company says it is, they stop doing the cases. Or better yet, wait until a few lawsuits hit the newspapers. They will be coming as it usually takes two years to complete treatment and it is just about due for a few lawsuits.
Recs
this stock just got crushed with a 30% loss but over all had been a rather good stock seeing it is nearing 1/2 its value it should make a come back next year, its an acquire on the way down and hold to recovery
Recs
down $6 to $22
Recs
Oct 16 Mad Money highlight. Has blown away numbers. Strong buy recommendation.
Recs
virtual monoply, beating est, no debt,
Recs
Cramer, Invisalign tooth straightening
Recs
my brother is a dentist. he swears by their product and training. this company offers high margin and good growth (with only a 5-6% marketshare. if dermatologists are doing botox, then it stands to reason that every kid - with non-perfect teeth will make their parents go for align's product. these guys are to teeth what nike is to feet.
Recs
I have been using this system for over 2 years now. I was a bit skeptical about this mode of treatment.... But now i am convinced that this system does work.... SO the product is great that's for sure besides :
1. after they bought over its competitor last year they are have an almost exclusive hold over the market
2. Personally I see a great demand for this kind of treatment with older adult patients..( because the other alternative of wearing traditional orthodontic wires and brackets does not appeal to this age group ). and it can work well with teenagers and young adults as well.
Recs
Great stock! No debt. Exclusive product . Invisible braces . Has patent no one else can infrenge on this suit was settle on this issue this year.
Recs
Great product...way better than braces...
Recs
Overvalued and likely heading lower. Competition will likely nix the dream.

RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 30 1 2 Next »